Rodriguez Arrieta LA, Rueda Galvis PA, Rueda Galvis MV, Pantoja Meneses SA, Yépez Rodriguez JM, Suarez Contreras FJ. When skin reactions interrupt bone therapy: severe cutaneous adverse reaction to romosozumab leading to treatment discontinuation. EJCRIM [Internet]. 2025 Aug. 25 [cited 2026 Nov. 3];12(9). Available from: https://ejcrim.com/index.php/ejcrim/article/view/5719